$AMRN I think we find out Tuesday why FDA triggered the ADCOM so late in the process, whether positive or negative. We know MO will be brought up, but will there be a voting question on its use or a voting question on a DDI study? If those two things don’t come up in the voting questions, I can’t image anything else that would be negative.
  • 7
  • 11